1. Conducting HIV vaccine trials in South Africa;Abdool Karim;Continuing Medical Education,2002
2. Altenroxel, L. (2002). Dispute puts SA's AIDS vaccine trial at risk. The Star, September 5.
3. Commentary;Ashcroft;Social Science & Medicine,2002
4. Bartholow, B. N., Buchbinder, S., Goli, V., Celum, C., Koblin, B., Marmor, M., & Cronin, P. (2002). HIV risk behavior change over 24 months of follow-up in a phase-III HIV vaccine efficacy trial. Paper presented at the XIV International AIDS Conference, Barcelona, August.
5. Bartholow, B.N., Buchbinder, S., Celum, C., Goli, V., Koblin, B., Para, M., Marmor, M., Novak, R.M., Mayer, K., Creticos, C., Orozco-Cronin, P., Popovic, V., & Mastro, T.D. (2004). HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial. Paper under review, Journal of AIDS.